Login / Signup

Tacrolimus 0.03% ointment treatment in exfoliative cheilitis: A randomised controlled clinical trial and monitoring blood concentration.

Junjiang LiuLiran ShiXiangjian WangFanglong WuMingjia HuJing HeMei LinHongmei WangHongmei Zhou
Published in: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology (2020)
Topical tacrolimus 0.03% ointment has good short-term efficacy and safety for treating EC.
Keyphrases
  • clinical trial
  • study protocol
  • open label
  • phase ii
  • wound healing
  • placebo controlled